How Much Niacinamide Per Day: Doses and Limits

Most adults who supplement niacinamide take between 250 and 500 mg per day for general wellness, while clinical research has tested doses as high as 1,000 to 3,000 mg per day for specific conditions. The right amount depends heavily on what you are trying to achieve, and the safety ceiling is considerably higher than many people assume. What makes niacinamide unusual among B vitamins is that the gap between the nutritional requirement and the doses used in medical studies is enormous, and the side-effect profile stays remarkably mild across most of that range.

Nutritional Needs Versus Supplement Doses

Your body needs only about 14 to 16 mg of niacin equivalents per day to prevent deficiency. That amount is easy to get from food alone, and outright deficiency (pellagra) is rare in developed countries. But the doses that show up in clinical trials for conditions like skin cancer prevention, inflammatory skin conditions, or joint health are typically 30 to 200 times that baseline requirement. This is not unusual for B vitamins used therapeutically, but it does mean you should think of niacinamide supplementation as a pharmacological decision, not just topping off a nutrient.

Regulatory bodies set different upper limits depending on which form of vitamin B3 they are evaluating. In Europe, the tolerable upper level for niacinamide specifically is 900 mg per day for adults, while the older U.S. figure of 35 mg per day was based on flushing caused by niacin (nicotinic acid), not niacinamide. That distinction matters because niacinamide does not cause flushing at any dose.¹ The 35 mg ceiling, in other words, does not really apply to niacinamide, and researchers routinely use doses far above it without seeing serious adverse effects.

The Most Studied Dose: 500 mg Twice Daily for Skin Cancer Prevention

The largest and most influential niacinamide trial to date used 500 mg twice daily, totaling 1,000 mg per day. In that phase 3 trial, people with a history of at least two nonmelanoma skin cancers were given either niacinamide or a placebo for 12 months. The niacinamide group developed roughly a quarter fewer new nonmelanoma skin cancers over that year, with an even larger reduction for squamous cell carcinomas specifically. Pre-cancerous spots called actinic keratoses also dropped measurably throughout the treatment period.²

Those results were striking enough to change clinical practice for some dermatologists, who now recommend 500 mg twice daily to patients with a strong history of sun-related skin cancers. But there are important caveats. The protective effect disappeared after participants stopped taking niacinamide, meaning this is ongoing prevention rather than a lasting change. And a broader look at the research shows that while the mechanistic rationale is strong, the overall evidence base is still described as mixed, with calls for more long-term trials to nail down the best dosing strategy and which patients benefit most.³

The mechanism behind this protection involves DNA repair. Niacinamide is the body’s primary raw material for making NAD+, a molecule that fuels an enzyme critical to repairing UV-damaged DNA. When skin cells have more NAD+ available, they can fix DNA breaks more efficiently and maintain their energy supply under stress.⁴ That is the same reason niacinamide is being studied for neuroprotection: nerve cells are also energy-hungry and vulnerable to metabolic stress.

What 500 mg Actually Does Inside Your Body

A small clinical trial directly measured what happens to blood NAD+ levels after different single doses of niacinamide. A 500 mg dose significantly raised NAD+ within 12 hours, while a 100 mg dose did not move the needle at all.⁵ This suggests there is a threshold effect: your body can handle and convert small dietary amounts through normal metabolism without any detectable surplus, but a larger bolus actually saturates those pathways and pushes NAD+ upward.

That said, the NAD+ boost from niacinamide appears to be acute and transient. A separate randomized trial comparing niacinamide head-to-head with two other NAD+ precursors, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), found that after 14 days of supplementation, niacinamide did not sustain elevated circulating NAD+ the way NR and NMN did. Niacinamide’s effect was more of a quick spike that faded, while the other two produced a more durable increase.⁶ This matters if your reason for supplementing is to maintain chronically higher NAD+ levels. Niacinamide is far cheaper than NR or NMN, but it may work through a different rhythm, useful in repeated daily doses rather than as a steady-state booster.

Higher Doses Used in Medical Research

Beyond the 1,000 mg per day skin-cancer protocol, researchers have tested niacinamide at substantially higher doses for other conditions. For osteoarthritis, one pilot study used 3,000 mg per day (divided into multiple doses throughout the day) and found that participants’ overall arthritis impact improved by about 29% compared to placebo, with improved joint mobility and a meaningful reduction in anti-inflammatory medication use. Side effects were mild, though slightly more common in the niacinamide group.⁷ That is one small study from the 1990s, and it has not been followed by the kind of large confirmatory trials that would make 3,000 mg a standard recommendation, but it illustrates that even triple the skin-cancer dose was tolerated in a research setting.

For inflammatory skin conditions like acne and rosacea, oral niacinamide at pharmacological doses has also shown promise as an alternative approach for managing inflammatory lesions.⁸ The exact doses studied vary, but they generally fall in the range of 500 to 1,500 mg per day, well above what you would get from diet.

Kidney Disease and Phosphate Control

One of the more specialized uses of niacinamide is in patients on dialysis, where high blood phosphate is a persistent and dangerous problem. Niacinamide blocks some of the intestinal absorption of phosphate, offering a different angle of attack from traditional phosphate binders. In one trial with dialysis patients, doses of 250 to 500 mg per day significantly reduced serum phosphate levels compared to placebo.⁹ An earlier study started patients at 500 mg per day and titrated upward, eventually averaging about 1,080 mg per day, with significant phosphate reductions and no hypercalcemia, a common side effect of other phosphate-lowering approaches.¹⁰

This use remains investigational. A review of the topic concluded that while niacinamide has potential as a tool for managing high phosphate in kidney disease, more safety and efficacy data are needed before it becomes a routine part of care.¹¹ If you are on dialysis, this is a conversation to have with your nephrologist, not something to self-prescribe.

Neuroprotection and Eye Health

Animal research has shown that niacinamide-enriched diets protect retinal nerve cells in models of glaucoma, preserving both the structure and metabolic function of the cells most vulnerable to the disease. Researchers have hypothesized that some of the short-term visual improvement already observed in glaucoma patients given niacinamide may come from protecting nerve cells that are stressed but not yet dead.¹² Human trials are underway but definitive dose recommendations for eye health do not yet exist. The doses being explored tend to mirror or exceed those used for skin cancer prevention.

Safety, Side Effects, and the Insulin Sensitivity Question

Niacinamide is genuinely well tolerated at doses up to about 1,000 mg per day in most research. The skin cancer trial, which ran for a full year at that dose, found no meaningful difference in adverse events between the niacinamide and placebo groups.² At higher doses, mild gastrointestinal discomfort becomes more likely, and the osteoarthritis trial at 3,000 mg per day did report a higher rate of minor side effects.⁷

One concern that deserves attention is insulin sensitivity. A study in people at risk for type 1 diabetes found that niacinamide reduced insulin sensitivity by about 24%.¹³ That is a substantial metabolic shift. It does not mean niacinamide causes diabetes, but it does raise a flag for people who already have insulin resistance or are managing blood sugar issues. If you fall into that category, you should involve your doctor before adding a high-dose niacinamide supplement.

A common point of confusion is whether niacinamide can damage the liver the way niacin can. High-dose niacin, particularly in time-release formulations, has a well-documented history of causing liver toxicity, sometimes within days of starting at high doses.¹⁴ Niacinamide is a different molecule and does not carry the same hepatotoxicity profile. At the doses used in published trials (up to about 3,000 mg per day), serious liver injury from niacinamide has not been a notable finding. Still, very high doses over long periods have not been studied exhaustively, and periodic liver function testing is reasonable if you are taking more than 1,000 mg daily on an ongoing basis.

Why Niacinamide and Niacin Are Not Interchangeable

Both niacinamide and niacin (nicotinic acid) are forms of vitamin B3, and both can be used by the body to make NAD+. But their side effect profiles and clinical uses diverge sharply. Niacin causes flushing, an intense skin reddening and warmth that many people find intolerable, especially at the doses used for cholesterol management (typically 1,000 to 3,000 mg per day). Niacinamide does not cause flushing at any dose.¹ On the flip side, niacin has established effects on blood lipids (raising HDL, lowering triglycerides) that niacinamide does not share. They are not substitutes for each other, and confusing the two when buying supplements or filling prescriptions can lead to unexpected side effects or missed therapeutic targets.

Niacinamide Versus NR and NMN for NAD+ Boosting

The supplement market now offers several compounds marketed as NAD+ boosters: niacinamide, nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN). All three feed into NAD+ production, but they take different routes through the body’s metabolic machinery. In a direct comparison, two weeks of NR or NMN supplementation raised circulating NAD+ levels in a sustained way, while niacinamide at the same duration produced only a transient, acute effect on the NAD+ metabolome.⁶

The proposed explanation is that NR and NMN are partly processed by gut bacteria into nicotinic acid, which then boosts NAD+ through a slower but more persistent pathway. Niacinamide, by contrast, is absorbed quickly and used through the salvage pathway, which is faster but burns through the dose more rapidly. The practical takeaway is that if your goal is specifically to raise and maintain systemic NAD+ levels, NR or NMN may be more effective per dose, though they cost considerably more. If your goal is skin cancer prevention, DNA repair support, or one of the other condition-specific benefits discussed above, the clinical evidence was built using plain niacinamide, and there is no reason to assume a more expensive precursor would perform better for those endpoints.

An additional wrinkle involves sirtuins, a family of enzymes involved in aging and cellular stress responses. In a test tube, niacinamide actually inhibits SIRT1, one of the most-studied sirtuins. But in living cells, the picture reverses: niacinamide is rapidly converted into NAD+, which sirtuins need as fuel. So the net cellular effect of niacinamide supplementation is likely to support sirtuin activity rather than block it, despite what simple in vitro experiments might suggest.¹⁵ This is one of those findings that generated confusion in the longevity community, where early reports of sirtuin inhibition made niacinamide sound counterproductive. The in-cell reality is more nuanced.

Topical Niacinamide Is a Separate Question

Many people encounter niacinamide through skincare products rather than oral supplements, and the dosing logic is completely different. Topical niacinamide is measured by concentration in the formula (typically 2% to 10%) rather than by milligrams consumed. The amount that actually penetrates the skin and reaches target cells is a fraction of what is in the bottle, and it acts locally rather than systemically. A 5% niacinamide serum does not raise your blood NAD+ levels the way an oral 500 mg tablet does.

Interestingly, the exact concentrations used in some clinical trials of topical products are not always disclosed. At least one recent controlled study testing a niacinamide-containing topical regimen after laser treatment noted that the precise concentrations of niacinamide in the formulation were proprietary and could not be published.¹⁶ This is a broader problem in the cosmeceutical world: branded formulations get tested as a package, but you cannot always tell which ingredient at which dose is doing the work. For consumers, the practical guidance is that topical niacinamide in the 4% to 5% range has the most consistent supporting evidence for reducing redness, improving skin texture, and supporting the skin barrier. Going above 10% does not clearly improve results and can cause irritation in some people.

If you are using both a topical niacinamide product and an oral supplement, there is no evidence that the two interact in a problematic way. They operate on different scales and through different delivery routes. The topical product works on the skin surface and the outermost living layers; the oral dose works systemically. Neither amplifies the other’s side effects, and many dermatologists recommend both simultaneously to patients with a history of sun damage.

Practical Dose Guidance by Goal

Pulling the research together, here is how the doses map to specific uses:

General wellness: 250 to 500 mg per day. This is where most over-the-counter supplements land, and the 500 mg dose is the lowest shown to acutely raise NAD+ levels in blood.
Skin cancer prevention: 500 mg twice daily (1,000 mg total), the protocol from the landmark phase 3 trial. This dose was safe and well tolerated over a full year.
Phosphate control in kidney disease: 250 to 1,000+ mg per day, titrated under medical supervision.
Joint health: Up to 3,000 mg per day in divided doses, based on limited pilot data. This is not a standard recommendation and should involve medical oversight.
Inflammatory skin conditions: Typically 500 to 1,500 mg per day, though the evidence base for specific dose optimization is still thin.

For most people exploring niacinamide supplementation without a specific medical condition, 500 mg once or twice daily is the dose range with the best balance of evidence and tolerability. If you are managing a specific condition, the dose should be guided by the clinical evidence for that condition and discussed with a healthcare provider, especially if you have diabetes, liver disease, or kidney disease. And if you are taking niacinamide purely to boost NAD+ over the long haul, it is worth knowing that NR and NMN may sustain that boost more effectively, though at a higher price and with less condition-specific clinical backing.

1
Journal of Drugs in Dermatology. New Onset Flushing due to Unauthorized Substitution of Niacin for Nicotinamide
2
PubMed. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention
3
PubMed Central. Skin Cancer Prevention and Antiaging: Role of Nicotinamide
4
PubMed Central. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair
5
ScienceDirect. A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects
6
PubMed Central. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans
7
PubMed. The effect of niacinamide on osteoarthritis: a pilot study
8
PubMed. Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review
9
PubMed. The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial
10
PubMed. Nicotinamide suppresses hyperphosphatemia in hemodialysis patients
11
PubMed Central. Nicotinamide and phosphate homeostasis in chronic kidney disease
12
PubMed Central. Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
13
PubMed. Nicotinamide’s effects on glucose metabolism in subjects at risk for IDDM
14
The American Journal of Medicine. Hepatic toxicity of unmodified and time-release preparations of niacin
15
PubMed Central. Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells
16
PubMed Central. Skin barrier repairing and anti-aging effects evaluation of a comprehensive topical regimen incorporating niacinamide, Pro-Xylane, and panthenol after PicoWay laser: a randomized controlled study